🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Gold Moves Lower; TransCode Therapeutics Shares Surge

Published 25/09/2023, 19:43
© Reuters.  Gold Moves Lower; TransCode Therapeutics Shares Surge
GC
-
HG
-
SI
-
FXXPc1
-
BCLI
-
SCYX
-
ALBPS
-
MORF
-
HSTECH
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday.

The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to 13,243.56. The S&P 500 also rose, gaining, 0.19% to 4,328.30.

Check This Out: Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday

Leading and Lagging Sectors

Energy shares rose by 1.2% on Monday.

In trading on Monday, consumer staples shares fell by 0.7%.

Top Headline

The Chicago Fed National Activity Index declined to -0.16 in August versus a revised reading of 0.07 in July.

Equities Trading UP

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares shot up 218% to $2.11 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Shares of ESS Tech, Inc. (NYSE: GWH) got a boost, shooting 24% to $1.7173. Honeywell International Inc (NASDAQ: HON) entered into a strategic collaboration with ESS Tech to advance technology development and market adoption of iron flow battery (IFB) energy storage systems.

Biophytis S.A. (NASDAQ: BPTS) shares were also up, gaining 54% to $1.4199 after the company and Skyepharma announced the signature of a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19.

Equities Trading DOWN

SCYNEXIS, Inc. (NASDAQ: SCYX) shares dropped 34% to $2.17 after the company announced it is recalling BREXAFEMME and temporarily halting clinical studies of ibrexafungerp due to the risk of cross contamination with a non-bacterial beta-lactam drug substance during the manufacturing process.

Shares of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) were down 33% to $0.55 after the FDA said it does not believe there is sufficient evidence to support that any of the assessed biomarkers for the company's ALS therapy is reasonably likely to predict clinical benefit.

Morphic Holding, Inc. (NASDAQ: MORF) was down, falling 37% to $23.19 after BTIG downgraded the stock from Buy to Neutral.

Also Check This Out: Vivani Medical And 2 Other Stocks Under $2 Insiders Are Buying

Commodities

In commodity news, oil traded down 0.4% to $89.68 while gold traded down 0.5% at $1,936.20.

Silver traded down 2% to $23.37 on Monday while copper fell 0.7% to $3.6705.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.62% London’s FTSE 100 fell 0.78% while Spain’s IBEX 35 Index fell 1.22% The German DAX fell 0.98% French CAC 40 declined 0.85%, while Italy’s FTSE MIB Index dipped 0.68%.

The Ifo Business Climate indicator for Germany fell to 85.7 in September from August's revised reading of 85.8. Producer prices in Spain fell 10% year-over-year in August versus a revised 8.6% decline in the previous month.

Asia Pacific Markets

Asian markets closed mixed on Monday, with Japan’s Nikkei 225 gaining 0.85%, Hong Kong’s Hang Seng Index falling 1.82% and China’s Shanghai Composite Index declining 0.54%. India’s S&P BSE Sensex, meanwhile, gained 0.1%.

Economics

The Chicago Fed National Activity Index declined to -0.16 in August versus a revised reading of 0.07 in July.

The Federal Reserve Bank of Dallas’ general business activity index for manufacturing in Texas declined to -18.1 in September from -17.2 a month ago.

Now Read This: Top 4 Tech Stocks That May Explode In Q3

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,590,470 cases with around 1,176,090 deaths. India confirmed a total of at least 44,998,520 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,729,180 cases of COVID-19 worldwide with more than 6,919,340 deaths.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.